Glen Eagle Advisors, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 913 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
Glen Eagle Advisors, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$88,903
-0.6%
2,042
-0.5%
0.02%
+4.3%
Q1 2022$89,448
-1.1%
2,053
+0.0%
0.02%
-4.2%
Q4 2021$90,485
+9.5%
2,052
-5.1%
0.02%0.0%
Q3 2021$82,607
-4.0%
2,162
+0.1%
0.02%
-11.1%
Q2 2021$86,015
+11.7%
2,160
+0.1%
0.03%0.0%
Q1 2021$77,008
-2.9%
2,158
+0.1%
0.03%
-12.9%
Q4 2020$79,335
-7.5%
2,156
-5.4%
0.03%
-18.4%
Q3 2020$85,785
-7.7%
2,279
+0.0%
0.04%
-20.8%
Q2 2020$92,900
+8.8%
2,278
+1.1%
0.05%
-20.0%
Q1 2020$85,390
-9.6%
2,254
+12.1%
0.06%
+17.6%
Q4 2019$94,508
+10.2%
2,011
+0.0%
0.05%
-10.5%
Q3 2019$85,780
+1.7%
2,010
-4.6%
0.06%
-1.7%
Q2 2019$84,377
-4.2%
2,108
+0.0%
0.06%
-9.4%
Q1 2019$88,031
+9.4%
2,107
+0.1%
0.06%
-5.9%
Q4 2018$80,432
-4.8%
2,105
+0.1%
0.07%
+13.3%
Q3 2018$84,494
-0.3%
2,103
+0.0%
0.06%
-9.1%
Q2 2018$84,730
+3.3%
2,102
+0.1%
0.07%
-2.9%
Q1 2018$82,049
+23.5%
2,100
+12.1%
0.07%
+17.2%
Q4 2017$66,451
-12.6%
1,873
+0.1%
0.06%
-18.3%
Q3 2017$76,004
+193.8%
1,872
+212.0%
0.07%
+238.1%
Q2 2017$25,872
+2.3%
6000.0%0.02%
-4.5%
Q1 2017$25,296
+9.5%
6000.0%0.02%
+4.8%
Q4 2016$23,1066000.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2021
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 5,993,336$264,217,00032.64%
Black Creek Investment Management Inc. 10,373,943$457,491,00012.20%
KAHN BROTHERS GROUP INC 1,438,569$63,440,893,0008.71%
EQUITY INVESTMENT CORP 2,932,078$129,305,0004.68%
JET CAPITAL INVESTORS L P 400,000$17,640,0004.67%
Eversept Partners, LP 1,503,700$66,313,1704.24%
NKCFO LLC 269,500$11,885,0003.82%
Camber Capital Management LP 2,500,000$110,250,0003.79%
CLIFFORD CAPITAL PARTNERS LLC 113,866$5,021,0003.75%
Robinson Value Management, Ltd. 97,677$4,308,0003.54%
View complete list of GLAXOSMITHKLINE PLC shareholders